Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-08-23
2011-08-23
Shafer, Shulamith H (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S139100, C424S143100, C530S387100, C530S387300, C530S387900, C530S388100, C530S388220
Reexamination Certificate
active
08003102
ABSTRACT:
The present invention provides antibodies that bind human CXCR4 and are characterized as having high affinity and strong neutralizing properties. The antibodies of the invention are useful in the treatment of tumorigenesis, including tumor growth, invasion, angiogenesis, or metastasis.
REFERENCES:
patent: 5776457 (1998-07-01), Lee et al.
patent: 5840856 (1998-11-01), Chuntharapai et al.
patent: 5994515 (1999-11-01), Hoxie
patent: 6863887 (2005-03-01), Murphy et al.
patent: 6949243 (2005-09-01), Mueller et al.
patent: 7138496 (2006-11-01), Hua et al.
patent: 2004/0132642 (2004-07-01), Hwang
patent: 2004/0209837 (2004-10-01), Kishimoto et al.
patent: 2007/0003558 (2007-01-01), von Andrian et al.
patent: 2007/0059308 (2007-03-01), Hua et al.
patent: 2010/0055088 (2010-03-01), Peled et al.
patent: 9217497 (1992-10-01), None
patent: 9948528 (1999-09-01), None
patent: 9950461 (1999-10-01), None
patent: 0138352 (2001-05-01), None
patent: 03066830 (2003-08-01), None
patent: 2004059285 (2004-07-01), None
patent: 2004074506 (2004-09-01), None
patent: 2006089141 (2006-08-01), None
patent: 2008060367 (2008-05-01), None
Carnec, X., et al., “Anti-CXCR4 Monoclonal Antibodies Recognizing Overlapping Epitopes Differ Significantly in Their Ability to Inhibit Entry of Human Immunodeficiency Virus Type 1”, Journal of Virology, 2005, 1930-1933, 79;3.
Muller, A., et al., “Involvement of chemokine receptors in breast cancer metastasis”, Nature, 2001, 50-56, 410.
Vermont-Desroches C., et al., “Evaluation of anti CXCR-4 Antibodies”, Diaclone Technical Document, CR4.1, Version 1-05.01, 2001.
Ghannadan, M., et al., “Detection of Novel CD Antigens on the Surface of Human Mast Cells and Basophils”, International Archives of Allergy and Immunology, 2002, 299-307, 127.
Yang, H., et al., “Antibody to CD14 like CXCR4-specific antibody 12G5 could inhibit CXCR4-dependent chemotaxis and HIV Env-mediated cell fusion”, Immunology Letters, 2003, 27-30, 88.
Paul, “Fv Structure and Diversity in Three Dimensions”, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295.
Rudikoff, et al, Proc. Natl. Acad. Sci. USA, Mar. 1982, 1979-1983, 79(6).
Colman P.M., Research in Immunology, 1994, 33-36, 145.
Dickerson Cindy Takeuchi
Marquis David Matthew
Obungu Victor H
Peng Sheng-Bin
Vaillancourt Peter Edward
Castetter Andrea M.
Eli Lilly and Company
Shafer Shulamith H
LandOfFree
Anti-CXCR4 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-CXCR4 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-CXCR4 antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2652562